Review of a review. Partial agonist activity of beta-adrenoceptor blocking drugs
Shanks, R.G.
European Heart Journal 2(3): 253-255
1981
ISSN/ISBN: 0195-668X PMID: 6115754 Document Number: 179268
Document emailed within 1 workday
Related Documents
Wirtzfeld, A.; Klein, G.; Bibra, H.V.; Sauer, E. 1985: Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity? International Journal of Clinical Pharmacology Therapy and Toxicology 23(1): 20-27Sørensen, E.V. 1993: Xamoterol--a beta-1-adrenoceptor partial agonist. Pharmacology and clinical use Danish Medical Bulletin 40(1): 111-121
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Krum, H.; Pillay, P. 1998: New drugs, old drugs. Beta-adrenoceptor blocking agents Medical Journal of Australia 168(5): 232-235
Lorimer, A.R.; Jones, J.V.; Clark, B.; Dunn, F.G.; Melville, D.; Lawrie, T.D. 1976: Indications for beta-adrenoceptor blocking drugs in hypertension Postgraduate Medical Journal 52(Suppl 4): 81-85
Kazanietz, M.G.; Enero, M.A. 1990: Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol Journal of Pharmacology and Experimental Therapeutics 252(2): 758-764
Hellenbrecht, D.; Enenkel, J. 1984: Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat Arzneimittel-Forschung 34(9): 980-983
Elonen, E. 1975: Effect of beta-adrenoceptor blocking drugs, physostigmine, and atropine on the toxicity of doxepin in mice Medical Biology 53(4): 231-237
Conde, S.; Corral, C.; Lissavetzky; Darias, V.; Martin, D. 1986: Synthesis and beta-adrenoceptor blocking activity of thiophenic analogues of metoprolol Il Farmaco; Edizione Scientifica 41(1): 80-88
Shibasaki, K.; Uchida, W.; Shirai, Y.; Inagaki, O.; Asano, M.; Takenaka, T. 1994: Pharmacological properties of YM-15430-1, a 1,4-dihydropyridine derivative with beta 1-adrenoceptor-blocking activity Archives Internationales de Pharmacodynamie et de Therapie 328(2): 213-224
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Jackson, E.A.; Sullman, S.A. 1984: Comparative review of beta-blocking agents Connecticut Medicine 48(4): 213-215
Oriowo, M.A.; Chapman, H.; Kirkham, D.M.; Sennitt, M.V.; Ruffolo, R.R.; Cawthorne, M.A. 1996: The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344 Journal of Pharmacology and Experimental Therapeutics 277(1): 22-27
Conway, J. 1980: The antihypertensive action of beta-adrenoceptor blocking agents Archives Internationales de Pharmacodynamie et de Therapie Suppl: 83-91
Gross, D.M.; Fisher, J.W. 1978: Effects of terbutaline, a synthetic beta adrenoceptor agonist, on in vivo erythropoietin production Archives Internationales de Pharmacodynamie et de Therapie 236(2): 192-201
Marlin, G.E.; Berend, N.; Harrison, A.C. 1979: Combined cholinergic antagonist and beta 2-adrenoceptor agonist bronchodilator therapy by inhalation Australian and New Zealand Journal of Medicine 9(5): 511-514
Mostaghim, R.; Maddox, Y.T.; Ramwell, P.W. 1986: Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents Journal of Pharmacology and Experimental Therapeutics 239(3): 797-801
Hellenbrecht, D.; Gortner, L. 1976: Correlations between hydrophobicity and non-specific pharmacological effects of beta-adrenoceptor blocking agents Polish Journal of Pharmacology and Pharmacy 28(6): 625-630
Schneider, R.E.; Bishop, H.; Kendall, M.J.; Quarterman, C.P. 1981: Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents International Journal of Clinical Pharmacology Therapy and Toxicology 19(4): 158-162